365 related articles for article (PubMed ID: 31399013)
1. Imbalance between CD8
Minning S; Xiaofan Y; Anqi X; Bingjie G; Dinglei S; Mingshun Z; Juan X; Xiaohui J; Huijuan W
Lupus; 2019 Sep; 28(10):1214-1223. PubMed ID: 31399013
[TBL] [Abstract][Full Text] [Related]
2. CD4
Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
[TBL] [Abstract][Full Text] [Related]
3. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
4. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
5. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
6. Phenotypical changes and clinical significance of CD4
Yuan S; Zeng Y; Li J; Wang C; Li W; He Z; Ye J; Li F; Chen Y; Lin X; Yu N; Cai X
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35732344
[TBL] [Abstract][Full Text] [Related]
7. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients].
Chen X; Wang LL; Cai B; Chen J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):588-90. PubMed ID: 16948902
[TBL] [Abstract][Full Text] [Related]
8. Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus.
Alvarado C; Alcocer-Varela J; Llorente L; Richaud-Patin Y; Cerbon M; Alarcon-Segovia D
J Autoimmun; 1994 Dec; 7(6):763-73. PubMed ID: 7888034
[TBL] [Abstract][Full Text] [Related]
9. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
10. Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection.
Wu CS; Chyuan IT; Chiu YL; Chen WL; Shen CY; Hsu PN
Rheumatology (Oxford); 2020 Nov; 59(11):3340-3349. PubMed ID: 32306043
[TBL] [Abstract][Full Text] [Related]
11. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
Comte D; Karampetsou MP; Yoshida N; Kis-Toth K; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2017 May; 69(5):1035-1044. PubMed ID: 28076903
[TBL] [Abstract][Full Text] [Related]
12. Relationship between T lymphocyte subsets and cortisol in systemic lupus erythematosus.
Shah D; Kiran R; Wanchu A; Bhatnagar A
Kathmandu Univ Med J (KUMJ); 2009; 7(27):213-9. PubMed ID: 20071865
[TBL] [Abstract][Full Text] [Related]
13. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus.
Mesquita D; Cruvinel WM; Araujo JA; Salmazi KC; Kallas EG; Andrade LE
Braz J Med Biol Res; 2014 Aug; 47(8):662-9. PubMed ID: 25098715
[TBL] [Abstract][Full Text] [Related]
15. CD8+CD28-, suppressive T cells in systemic lupus erythematosus.
Tulunay A; Yavuz S; Direskeneli H; Eksioglu-Demiralp E
Lupus; 2008 Jul; 17(7):630-7. PubMed ID: 18625635
[TBL] [Abstract][Full Text] [Related]
16. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
17. Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():718359. PubMed ID: 34867947
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.
Zhang L; Bertucci AM; Ramsey-Goldman R; Burt RK; Datta SK
J Immunol; 2009 Nov; 183(10):6346-58. PubMed ID: 19841178
[TBL] [Abstract][Full Text] [Related]
20. CD3(+)CD8(+)CD28(-) T Lymphocytes in Patients with Lupus Nephritis.
Żabińska M; Krajewska M; Kościelska-Kasprzak K; Klinger M
J Immunol Res; 2016; 2016():1058165. PubMed ID: 27446964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
